ARGX vs NAMS: Side-by-Side Comparison
Compare Argen X SE (ARGX) and NewAmsterdam Pharma Company NV (NAMS) side by side: market cap USD 58.44B vs USD 4.07B. Financials, growth and model signals on Bullrun.
| Metric | ARGX | NAMS |
|---|---|---|
| Company | Argen X SE | NewAmsterdam Pharma Company NV |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 58.44B | USD 4.07B |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | — | USD 22.50M |
| Revenue growth YoY | — | -50.6% |
| Net income | — | USD -203.00M |
| Gross margin | — | — |
| Diluted EPS | — | -1.72 |